Med-tech firms raising money in public or private financings, including: Establishment Labs.

Biopharmas raising money in public or private financings, including: Clarus, Nkarta, Sunshine, Valneva.

Cambridge Innovation Capital (CIC) has closed its oversubscribed Fund II at £225 million (US$287 million) and is moving from its previous model of open-ended investing to a traditional fixed-term venture capital fund. The money will be dedicated to spinouts from Cambridge University, with CIC investing in series A rounds, but also following on as companies mature and their capital requirements increase.

Med-tech firms raising money in public or private financings, including: Signal 1, Stentit.

Biopharmas raising money in public or private financings, including: Exogene, Forcefield, Healome, Hemostemix, Hillevax, Immunocore, Mitorx, Salarius, Savara, Scynexis, Syncona, Takeda.

Med-tech firms raising money in public or private financings, including: Bioconnection.

Biopharmas raising money in public or private financings, Helix, Noxxon.

Med-tech firms raising money in public or private financings, including: Circle CVI, Endra Life Sciences, Mendel, Nota Labs, Reify Health, Thoma Bravo.

Biopharmas raising money in public or private financings, including: Bristol Myers Squibb, Dermata, Octant, Xinvento.